New Key Statistics Module, Z-Score and F-Score
SZSE:300039 Key Ratios
Market Cap ¥ M | 5,596.10 |
Enterprise Value ¥ M | 4,719.45 |
P/E(ttm) | 16.61 |
PE Ratio without NRI | 16.31 |
Forward PE Ratio | -- |
Price/Book | 1.48 |
Price/Sales | 3.47 |
Price/Free Cash Flow | 15.92 |
Price/Owner Earnings | 17.73 |
Payout Ratio % | 0.18 |
Revenue (TTM) ¥ M | 1,610.00 |
EPS (TTM) ¥ | 0.32 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | -4.70 |
5-y EBITDA Growth Rate % | -0.10 |
y-y EBITDA Growth Rate % | 31.00 |
EV-to-EBIT | 14.08 |
EV-to-EBITDA | 14.08 |
PEG | -- |
Shares Outstanding M | 1,046.00 |
Net Margin (%) | 20.88 |
Operating Margin % | 20.80 |
Pre-tax Margin (%) | 24.15 |
Quick Ratio | 4.26 |
Current Ratio | 4.70 |
ROA % (ttm) | 7.45 |
ROE % (ttm) | 8.56 |
ROIC % (ttm) | 8.48 |
Dividend Yield % | 1.86 |
Altman Z-Score | 8.50 |
SZSE:300039 Number of Guru Trades
SZSE:300039 Volume of Guru Trades
Gurus Latest Trades with SZSE:300039
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300039 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Kaibao Pharmaceutical Co Ltd Insider Transactions
No Available Data